Alert: New Earnings Report (2/28/24)-Editas Medicine Inc (NASDAQ: EDIT).
Editas Medicine Inc (NASDAQ: EDIT) has reported a loss for its fourth fiscal quarter (ending December 31) of $-0.23 versus a loss $-0.88 for the same period a year ago. This result exceeded the consensus […]